Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study AZ3110866, a Fixed Dose Study of SB-742457 Versus Placebo When Added to Existing Donepezil Treatment in Subjects With Mild-to-moderate Alzheimer's Disease

NCT00710684 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00710684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00710684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study AZ3110866, a Fixed Dose Study of SB-742457 Versus Placebo When Added to Existing Donepezil Treatment in Subjects With Mild-to-moderate Alzheimer's Disease
Lead sponsor
GlaxoSmithKline
Phase
Phase 2
Overall status
Completed
Start date
July 1, 2008
Completion date
November 16, 2010
Enrollment
682 (actual)
Sites
102

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease